Massachusetts Financial Services
EBS icon

Massachusetts Financial Services’s Emergent Biosolutions EBS Stock Holding History

Massachusetts Financial Services’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-26,878
Closed -$198K – 847
2023
Q2 		$198K Sell
26,878
-634
-2% -$5.88K ﹤0.01% 815
2023
Q1 		$285K Sell
27,512
-777
-3% -$9.39K ﹤0.01% 824
2022
Q4 		$334K Buy
28,289
+598
+2% +$9.25K ﹤0.01% 828
2022
Q3 		$581K Sell
27,691
-252
-0.9% -$7.01K ﹤0.01% 808
2022
Q2 		$867K Buy
27,943
+140
+0.5% +$4.78K ﹤0.01% 785
2022
Q1 		$1.14M Buy
27,803
+285
+1% +$12.6K ﹤0.01% 790
2021
Q4 		$1.2M Sell
27,518
-558
-2% -$25.2K ﹤0.01% 809
2021
Q3 		$1.41M Sell
28,076
-369
-1% -$22.3K ﹤0.01% 809
2021
Q2 		$1.79M Buy
28,445
+243
+0.9% +$15.6K ﹤0.01% 792
2021
Q1 		$2.62M Sell
28,202
-3,347
-11% -$343K ﹤0.01% 735
2020
Q4 		$2.83M Buy
31,549
+6,796
+27% +$624K ﹤0.01% 704
2020
Q3 		$2.56M Buy
24,753
+837
+3% +$90.2K ﹤0.01% 696
2020
Q2 		$1.89M Sell
23,916
-612
-2% -$45.6K ﹤0.01% 692
2020
Q1 		$1.42M Buy
+24,528
New +$1.41M ﹤0.01% 712
2018
Q4 		– Sell
-31,970
Closed -$2.1M – 861
2018
Q3 		$2.1M Sell
31,970
-74
-0.2% -$4.32K ﹤0.01% 717
2018
Q2 		$1.62M Buy
32,044
+4,388
+16% +$229K ﹤0.01% 730
2018
Q1 		$1.46M Buy
27,656
+517
+2% +$25.8K ﹤0.01% 727
2017
Q4 		$1.26M Buy
27,139
+4,432
+20% +$187K ﹤0.01% 734
2017
Q3 		$918K Buy
+22,707
New +$822K ﹤0.01% 759
2014
Q3 		– Sell
-29,945
Closed -$673K – 885
2014
Q2 		$673K Sell
29,945
-15,095
-34% -$352K ﹤0.01% 829
2014
Q1 		$1.14M Sell
45,040
-3,040
-6% -$76.8K ﹤0.01% 746
2013
Q4 		$1.11M Sell
48,080
-3,590
-7% -$74.8K ﹤0.01% 719
2013
Q3 		$984K Sell
51,670
-1,890
-4% -$33.7K ﹤0.01% 720
2013
Q2 		$772K Buy
+53,560
New +$776K ﹤0.01% 737

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Massachusetts Financial Services's EBS Position: Q3 2023 in Review

Massachusetts Financial Services sold out of Emergent Biosolutions (EBS) in Q3 2023, closing a stake of 26,878 shares — an estimated $198K sold.

Massachusetts Financial Services first reported a position in EBS in Q2 2013 and held it in 24 quarters. The position peaked at $2.83M in Q4 2020. 162 funds tracked by Wall St. Rank hold EBS as of Q3 2023.

  • Massachusetts Financial Services reported no remaining Emergent Biosolutions position as of Q3 2023 after selling out during the quarter.
  • Massachusetts Financial Services sold 26,878 Emergent Biosolutions shares in Q3 2023, an estimated $198K.
  • Massachusetts Financial Services first reported a position in Emergent Biosolutions in Q2 2013 and held it in 24 quarters.
  • Massachusetts Financial Services's Emergent Biosolutions position peaked at $2.83M in Q4 2020.
  • 162 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2023.

Based on Massachusetts Financial Services's 13F filing for Q3 2023, filed 8 Nov 2023.